Clinical Study

Risk Factors for Developing Nonmelanoma Skin Cancer after Lung Transplantation

Figure 2

Skin cancer-free survival after lung transplantation. Kaplan-Meier plot showing the NMSC- or precancerous lesion-free survival after first lung transplantation comparing patients from the former everolimus arm, who remained on everolimus until dermatologic exam (“quasi per protocol”), to all other patients. Overall, 90 patients are included and analyzed with log-rank test for difference in median skin cancer-free survival (P=.47). NMSC, nonmelanoma skin cancer.